Sensitivity, Specificity, and Cost-Benefit Effect Between Primary Human Papillomavirus Testing, Primary Liquid-Based Cytology, and Co-Testing Algorithms for Cervical Lesions. [PDF]
Woo CG +5 more
europepmc +1 more source
Comparison of Clinical Efficacy of Liquid-Based Cytology and High-Risk Human Papillomavirus Testing With Partial Genotyping in Cervical Screening of Women Below 30 Years Old. [PDF]
Ang JX, Tay SK.
europepmc +1 more source
[TruScreen Combined With High-Risk Human Papillomavirus Testing vs Thinprep Cytology Test Combined With High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: A Comparative Clinical Study]. [PDF]
Yang Y +5 more
europepmc +1 more source
Attitude to cervical cancer screening and human papillomavirus testing experience in self-sampled Nigerian women. [PDF]
Olumodeji AM +6 more
europepmc +1 more source
Scoping review protocol on the perception and attitude of women on methods for collecting cervicovaginal samples for human papillomavirus testing in sub-Saharan Africa. [PDF]
Andrew-Bassey UI +3 more
europepmc +1 more source
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System. [PDF]
Parker SL +12 more
europepmc +1 more source
Primary human papillomavirus testing by clinician- versus self-collection: Awareness and acceptance among cervical cancer screening-eligible women. [PDF]
MacLaughlin KL +7 more
europepmc +1 more source
Related searches:
Human papillomavirus testing and screening
Best Practice & Research Clinical Obstetrics & Gynaecology, 2005Cervical cancer is a largely preventable disease through the detection, treatment and follow-up of its precursors. Traditionally, this has been accomplished through screening women with cervical cytology, and referring women with abnormal cytology for colposcopy, histological sampling and treatment. In organized programmes that achieve wide coverage of
L A, Denny, T C, Wright
openaire +2 more sources

